OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TOG55

Thai Optical Group PCL

Medical Equipment, Supplies & DistributionVerified

Thai Optical Group PCL maintains a debt-to-equity ratio of 0.55, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized by a current ratio of 1.76, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company reports a return on equity (ROE) of 4.76% and a return on assets (ROA) of 2.67%. These figures suggest that the company is generating returns, but at a relatively modest rate compared to industry benchmarks. The operating margin, calculated as operating income divided by revenue, is 15.76%, which is a key metric for evaluating operational efficiency in the medical equipment and supplies industry. The company's revenue is primarily concentrated in its domestic market, with no disclosed international revenue segments. This concentration may expose the company to regional economic fluctuations and regulatory changes in Thailand. The lack of geographic diversification could limit growth opportunities and increase vulnerability to local market conditions. Looking ahead, the company's growth trajectory is expected to be influenced by its capital expenditure and operating cash flow. The company's capital expenditure for the period was negative at -24.264 million THB, indicating a reduction in capital spending. The operating cash flow of 165.678 million THB suggests the company is generating positive cash from operations, which is a positive sign for its ability to fund future growth and meet obligations. The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The key risk flag of negative net cash after subtracting total debt highlights the need for careful liquidity management. The dilution risk is low, indicating that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. Recent events and filings have not disclosed any major strategic shifts or significant operational changes. The company's financial performance and risk profile remain stable, with no immediate signs of distress or aggressive expansion.

30-day price · TOG-0.15 (-2.2%)
Low$6.35High$6.95Close$6.65As of15 May, 00:00 UTC
Profile
CompanyThai Optical Group PCL
TickerTOG.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Thai Optical Group PCL operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in Thailand and potentially other markets.

Classification. Thai Optical Group PCL is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Thai Optical Group PCL maintains a debt-to-equity ratio of 0.55, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized by a current ratio of 1.76, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company reports a return on equity (ROE) of 4.76% and a return on assets (ROA) of 2.67%. These figures suggest that the company is generating returns, but at a relatively modest rate compared to industry benchmarks. The operating margin, calculated as operating income divided by revenue, is 15.76%, which is a key metric for evaluating operational efficiency in the medical equipment and supplies industry. The company's revenue is primarily concentrated in its domestic market, with no disclosed international revenue segments. This concentration may expose the company to regional economic fluctuations and regulatory changes in Thailand. The lack of geographic diversification could limit growth opportunities and increase vulnerability to local market conditions. Looking ahead, the company's growth trajectory is expected to be influenced by its capital expenditure and operating cash flow. The company's capital expenditure for the period was negative at -24.264 million THB, indicating a reduction in capital spending. The operating cash flow of 165.678 million THB suggests the company is generating positive cash from operations, which is a positive sign for its ability to fund future growth and meet obligations. The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The key risk flag of negative net cash after subtracting total debt highlights the need for careful liquidity management. The dilution risk is low, indicating that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. Recent events and filings have not disclosed any major strategic shifts or significant operational changes. The company's financial performance and risk profile remain stable, with no immediate signs of distress or aggressive expansion.
Key takeaways
  • Thai Optical Group PCL maintains a moderate level of leverage with a debt-to-equity ratio of 0.55.
  • The company's ROE of 4.76% and ROA of 2.67% indicate modest profitability.
  • Revenue is concentrated in the domestic market, increasing exposure to local economic and regulatory risks.
  • The company's operating cash flow of 165.678 million THB supports its liquidity position.
  • The company faces a medium liquidity risk and a low dilution risk.
  • No major strategic or operational changes have been disclosed in recent filings.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$844.5M
Gross profit$168.6M
Operating income$133.1M
Net income$111.6M
R&D
SG&A
D&A
SBC
Operating cash flow$165.7M
CapEx-$24.3M
Free cash flow$142.5M
Total assets$4.18B
Total liabilities$1.83B
Total equity$2.35B
Cash & equivalents$278.8M
Long-term debt$1.28B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$2.38B$340.7M$310.1M$178.7M
FY-3$2.92B$436.5M$403.6M$160.4M
FY-2$2.99B$492.2M$425.7M-$491.1M
FY-1$3.48B$506.1M$412.2M-$151.5M
FY0$3.54B$401.3M$334.5M$49.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.89B$1.96B$157.9M
FY-3$3.30B$2.11B$271.0M
FY-2$4.05B$2.24B$168.4M
FY-1$4.40B$2.34B$209.8M
FY0$4.57B$2.46B$164.2M
PeriodOCFCapExFCFSBC
FY-4$236.7M-$157.4M$178.7M
FY-3$436.8M-$181.3M$160.4M
FY-2$359.6M-$781.5M-$491.1M
FY-1$611.2M-$474.9M-$151.5M
FY0$604.0M-$357.0M$49.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$844.5M$133.1M$111.6M$142.5M
FQ-6$944.8M$149.0M$119.0M$46.3M
FQ-5$857.6M$85.8M$67.7M-$192.4M
FQ-4$829.9M$138.3M$113.9M$65.4M
FQ-3$898.7M$115.9M$98.4M$54.8M
FQ-2$871.4M$62.1M$41.5M$17.9M
FQ-1$838.2M$94.9M$80.9M-$39.0M
FQ0$930.2M$128.4M$113.7M$133.7M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$4.18B$2.35B$278.8M
FQ-6$4.27B$2.25B$322.8M
FQ-5$4.39B$2.23B$224.6M
FQ-4$4.40B$2.34B$209.9M
FQ-3$4.58B$2.44B$269.0M
FQ-2$4.43B$2.36B$211.1M
FQ-1$4.50B$2.35B$164.0M
FQ0$4.57B$2.46B$164.3M
PeriodOCFCapExFCFSBC
FQ-7$165.7M-$24.3M$142.5M
FQ-6$389.6M-$151.5M$46.3M
FQ-5$462.3M-$371.2M-$192.4M
FQ-4$611.2M-$474.9M$65.4M
FQ-3$134.5M-$111.9M$54.8M
FQ-2$372.8M-$206.9M$17.9M
FQ-1$544.9M-$305.8M-$39.0M
FQ0$604.0M-$357.0M$133.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.35B
Net cash-$1.00B
Current ratio1.8
Debt/Equity0.6
ROA2.7%
ROE4.8%
Cash conversion1.5%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricTOGActivity
Op margin15.8%3.9% medp25 -31.3% · p75 14.4%top quartile
Net margin13.2%2.4% medp25 -30.5% · p75 11.1%top quartile
Gross margin20.0%46.7% medp25 28.2% · p75 63.1%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-2.9%-4.8% medp25 -11.6% · p75 -2.4%above median
Debt / equity55.0%17.9% medp25 2.7% · p75 52.2%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:12 UTC#97852a74
Market quoteclose THB 6.80 · shares 0.47B diluted
no public URL
2026-05-10 10:12 UTC#f9f2c63a
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 18:16 UTCJob: d7f392d1